Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc is a leading biotechnology company that specializes in discovering, developing, and commercializing innovative medicines for serious diseases. With a primary focus on cystic fibrosis, a genetic disease that affects the lungs and digestive system, Vertex has developed several breakthrough drugs, including Kalydeco, Orkambi, Symdeko, and Trikafta, that have transformed the treatment of this condition. The company is also dedicated to developing therapies for other serious diseases, such as sickle cell disease and beta-thalassemia. Through its innovative research and development programs, Vertex is committed to advancing science and improving the lives of patients worldwide. Headquartered in Boston, Massachusetts, Vertex has a global presence with operations in multiple countries.